Dr. Dan Holtzclaw Publishes First Pterygoid Dental Implants Textbook this Summer

With his extensive credentials and qualifications, he is able to perform this complex procedure, allowing him to help many patients who are turned down for implants at other practices.

Austin, TX (PRWEB)
June 19, 2020

Dr. Dan Holtzclaw—a board-certified specialist in dental implants in Austin, TX—will publish a first-of-its-kind textbook on pterygoid implants later this summer. Dr. Holtzclaw has placed more than 25,000 implants to date, has published in excess of 60 articles in peer-reviewed dental journals, and has lectured on same-day, zygomatic, and pterygoid implants at conferences worldwide. Named among the World’s Top 100 Doctors by Global Summits Institute, he is one of a limited number of implant surgeons who perform pterygoid implant procedures, which help patients with severe bone loss qualify for dental implants.

The upcoming hardcover textbook will feature over 200 full-color pages devoted solely to pterygoid dental implants used in full-arch, immediate load protocols. It will detail the history of pterygoid implants, anatomy pertinent to the placement of pterygoid implants, indications and contraindications for pterygoid implants, surgical technique, how to deal with complications, prosthetic considerations for pterygoid implants, and many sample cases.

Pterygoid implants are placed in the upper jaw of patients who have lost a significant amount of jawbone and cannot support dental implants. They are much longer than standard implants, extending from the tooth root area to the pterygoid processes of the sphenoid bone. Dr. Holtzclaw is a Diplomate of both the International Congress of Oral Implantologists and the American Board of Periodontology, for which he is subject to recertification every six years. With his extensive credentials and qualifications, he is able to perform this complex procedure, allowing him to help many patients who are turned down for implants at other practices.

Dr. Holtzclaw’s practice, Austin Dental Implant Center, takes a comprehensive and collaborative approach to dental implant treatment. Periodontists, oral surgeons and even lab technicians all work at the same state-of-the-art practice, offering everything patients need. Beyond specialized techniques like pterygoid and zygomatic dental implant surgery, they also use on-site technology including their Zirkonzahn™ laboratory equipment, cone beam CT scanner, and hospital-grade anesthesia monitors to offer a truly unique advantage.

Those seeking dental implants in Austin, TX, particularly those who have suffered extensive bone loss in their jaws, can connect with Dr. Holtzclaw at Austin Dental Implant Center by calling 512-375-0050 or visiting http://www.austindentalimplantcenter.com.

Information about Dr. Holtzclaw’s upcoming textbook is available at http://www.pterygoidimplantbook.com. Those who order a copy of the book in advance can save 25 percent on the standard price.

About the Practice

Austin Dental Implant Center was founded by Dr. Dan Holtzclaw, one of the world’s leading authorities on full arch immediately loaded dental implant treatment. Using experience from thousands of dental implant procedures, Dr. Holtzclaw pioneered the DIAsmile™ implant teeth-in-a-day treatment concept, which allows patients to receive a new dental implant smile in just one day. With an in-house laboratory utilizing world-class Zirkonzahn™ technology, staff oral surgeons, staff prosthodontists, and experienced dental technicians, Austin Dental Implant Center is able to provide industry leading dental implant treatment in one convenient location, eliminating the need for patients to travel to multiple offices, as is required with most traditional dental offices.

To learn more about the Austin Dental Implant Center advantage visit http://www.austindentalimplantcenter.com or call 512-375-0050.

Share article on social media or email:

ARLINGTON, Va. (PRWEB)
June 19, 2020

Per IVD market research firm Kalorama Information there is an opportunity for test makers and investors in Chagas disease diagnostics. Chagas is a particularly underpublicized and harmful disease and current tests are inadequate to catch all cases. Recently the Defense Department was concerned enough to embark on a study after concerns about a principally Latin American disease reaching U.S. Army bases in the Southwest. In Kalorama information’s Emerging Infectious Testing report, Chagas is identified as one of the company’s Top Emerging Infectious Disease threats.

Chagas disease or American Trypanosomiasis represents the third largest tropical disease burden worldwide, after malaria and schistosomiasis. The disease is caused by the protozoan parasite T cruzi, which is transmitted to humans by blood-sucking insects of the family Reduviidae (Triatominae).

In Central and South America, Chagas kills more people than any other parasite-borne disease, including malaria and has a higher incidence-death rate than HIV/AIDS. In spite of this there are still no reliable data on its incidence. There is no vaccine against Chagas disease. Patients in the acute phase are generally treated with nifurtimox and benznidazole, which are highly toxic. There are no drugs to treat the chronic form of Chagas disease.

Doctors in the United States that treat people with Chagas disease, a parasitic illness transmitted by the “kissing bug” in the Americas, are increasingly worried about the estimated 30,000 to 45,000 people that are at increased risk of complications from COVID-19 because they have Chagas-related heart problems. As an indication of that concern, the U.S. Department of Defense has granted 700,000 to Texas State University to conduct a study assessing the threat of Chagas disease to military bases. https://www.sanmarcosrecord.com/news/texas-state-university-study-chagas-disease-threat-military.

Diagnosis of Chagas disease can be made by observation of the parasite in a blood smear by microscopic examination. A thick and thin blood smear are made and stained for visualization of parasites. but better tests are sought.

Chembio, Bioconcept and Altona Diagnostics are among the companies that produce tests for Chagas. Last year, a study found that a combination of marketed rapid point-of-care (POC) diagnostics was useful in screening for Chagas disease in a study conducted in Bolivia. The results compared well with the gold standard enzyme-linked immunosorbent assay (ELISA) approach, which is a challenge in low-resource settings, researchers reported on December 19 in PLOS Neglected Tropical Diseases.

Kalorama says that molecular testing is the most effective technique, however it is not widely available for screening programs. There is some expectation that current advancements in miniaturization may lead to cost-effective molecular devices. In the meantime major health organizations have been motivated to take action.

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals.

Share article on social media or email:

Cisive Named Best Solution Provider of the Year by CEO Views Magazine

As part of our commitment to support businesses during these unprecedented times and to help ensure the safety of their people, Cisive recently launched our SAFE19 COVID-19 Clearinghouse and CONTACT19 contact tracing solutions.

HOLTVILLE, N.Y. (PRWEB)
June 19, 2020

Cisive, a global provider of compliance-driven human capital management and risk management solutions, recently announced the company was named by CEO Views magazine as Best Solution Provider of the Year 2020. This distinction recognizes the best solution provider who offers the best in class service in the technology landscape.

“It is an honor for Cisive to be recognized as best solution provider of the year by CEO Views magazine,” said James Owens, President and CEO at Cisive. “This distinction is especially meaningful during the Coronavirus pandemic. As part of our commitment to support businesses during these unprecedented times and to help ensure the safety of their people, Cisive recently launched our SAFE19 COVID-19 Clearinghouse and CONTACT19 contact tracing solutions. More than ever, we are focused on delivering innovative technological solutions that provide the HR community with the key information to meet their hiring goals and critical business needs while focusing on the safety of their staff.”

In addition to being named as Best Solution Provider of the Year by CEO Views, Cisive has also been named as a Top 10 Pre-Employment Screening Company by HR Tech Outlook and as one of 30 Admired Companies to Watch in 2020 by CIO Bulletin. For more information about Cisive’s suite of solutions, visit http://www.Cisive.com.

About Cisive

Cisive is a global leader in compliance-driven human capital and risk management solutions, providing onboarding and pre-employment background screening solutions to address the complex challenges and needs of large enterprises with dedicated, in-country account management teams committed to customer satisfaction. Cisive is accredited by the Professional Background Screeners Association (PBSA) and was named for the third consecutive year by HRO Today to the 2019 Baker’s Dozen Customer Satisfaction rankings of Top Pre-Employment Screening Providers, in addition to being named Company of the Year by CIO Review. The company and its brands serve clients in financial services, transportation, telecom/media, healthcare, utilities and the home services end-markets, among others. For additional information, please visit http://www.cisive.com.

Share article on social media or email:

The city of Johannesburg designated the Peace Education Program as an Essential Service to help displaced people during the COVID-19 pandemic.

I thought I was homeless, but now I know that I have a home inside me.

LOS ANGELES (PRWEB)
June 19, 2020

The Prem Rawat Foundation (TPRF) has always viewed peace as a fundamental human need, and the Johannesburg Department of Social Development has now given credence to that idea, designating Peace Education Program facilitators as Essential Service Providers in South Africa.

As part of Johannesburg’s efforts to limit the spread of the COVID-19 virus, the city has set up shelters to house the homeless, offering crucial services to them while maintaining strict safety measures. The Peace Education Program is one of those services, helping people discover their own inner strength and personal peace during these trying times.

The peace education workshops are being offered in six shelters, and more than 200 people have participated, offering enthusiastic feedback.

“I thought I was homeless, but now I know that I have a home inside me,” said one of the participants. “Please continue with the program because we need it.”

Peace Education Program volunteers are using great care to facilitate the workshops without putting themselves or anyone else at risk for getting sick by wearing masks, sanitizing all materials and taking other precautions. The appreciation of the participants is making all of the effort worth it, say members of the team.

“When the Peace Education Program asked for volunteers to facilitate in shelters, I was excited and nervous at the same time. Excited because I was going to be able to go out for a moment during the lockdown; nervous because I didn’t know what to expect,” says Noma, one of the volunteer facilitators. “When we started, I couldn’t believe it—the gratitude for the message, the understanding—it is really humbling me. Every session is an experience I wouldn’t trade for anything. I’m grateful for being part of the program.”

Each Peace Education Program workshop features video excerpts of TPRF Founder Prem Rawat’s inspiring presentations on themes such as Dignity, Choice, Hope and Contentment. Facilitated reflection time, participant discussions, workbook activities and reading materials vary the workshops, making them fun and adaptable.

TPRF provides access to the course materials to organizations and volunteers free of charge, making the Peace Education Program readily available to diverse populations in more than 70 countries and in over 30 languages.

Any individual or organization can apply to TPRF for a free license to offer the course to interested groups.

Learn more about the Peace Education Program and how to apply for a license here.

TPRF also offers several other initiatives to address the fundamental human needs of food, water and peace across the world.

Learn about all of the different ways that TPRF is providing care during the pandemic here.

Share article on social media or email:

For too long, women’s health 40+ has been treated as shameful, but with GenX women aging into midlife, demands for menopause information, community and solutions are on the rise,” said Jill Angelo, co-founder and CEO of Gennev.

SEATTLE (PRWEB)
June 19, 2020

To support 38 million women juggling menopause symptoms, Gennev (http://www.gennev.com) today announced a first-of-its-kind Menopause Journey Map with five Menopause Types. Created by evaluating data from 50,000 Menopause Assessments, Gennev’s new Menopause Journey Map informs a woman if she is in menopause and where she is in the journey. This work paves the way for women to track their health through perimenopause and post-menopause for the first time and understand what’s happening, get solutions, and manage symptoms.

“For too long, women’s health 40+ has been treated as shameful, but with GenX women aging into midlife, demands for menopause information, community and solutions are on the rise,” said Jill Angelo, co-founder and CEO of Gennev. “The healthcare industry has been stubborn to evolve, but now we have the data, software, diagnostics, products and services that allow us to tackle menopause symptoms head on. We have the ability to create the What to Expect When You’re Expecting for menopause.”

Gennev’s path to creating the Menopause Journey Map began in 2017 with the creation of the industry’s most comprehensive menopause questionnaire – the Gennev Menopause Assessment – created by Rebecca Dunsmoor-Su, MD, MCSE, OB/GYN, North American Menopause Society (NAMS)-certified practitioner, and Chief Medical Officer at Gennev. Since then, over 50,000 women have taken the Menopause Assessment, which Dr. Dunsmoor-Su used to validate Gennev’s five Menopause Types. Gennev, which developed the industry’s first telehealth platform for menopause, combines medical science and lifestyle behaviors to help women take control of their health in the second half of life…starting with menopause. The company aims to help 1 million women improve their menopause experience in 2020.

“Every woman that reaches middle age will experience some level of menopause symptoms. Left untreated, these symptoms can lead to a significant reduction in quality of life,” said Dunsmoor-Su. “ We’re excited to deliver the Menopause Journey Map to help set expectations for women and offer predictive solutions for symptom relief, something that’s never been done before. In the future, we hope that this important body of work will lend itself to future innovations in women’s health.”

First-Of-Its-Kind Menopause Journey Map

Similar to how women have tracked their pregnancy through trimesters for decades, Gennev’s Menopause Map breaks menopause into 5 types. Below is an overview of each Menopause Type (detailed overview of Menopause Types is available here):

*Menopause Type 1: Women are pre-menopause and starting to see some perimenopausal symptoms with early irregular menses, occasional hot flashes, some (irregular) mood symptoms. Many women experience exacerbation of PMS.

*Menopause Type 2: Women are perimenopausal and starting to experience irregular and spaced periods that are often heavy. Skipping periods is normal during this phase and can last up to a year after last menses. Women may experience symptoms of hot flashes, night sweats, sleep disturbances, and mood changes.

*Menopause Type 3: Women in this phase are in early menopause, which lasts approximately 1 to 10 years after last menses. Women will still experience some symptoms, but symptoms will wane later in this stage. Vaginal symptoms tend to appear 2 to 3 years after the last period. Women may notice brain, skin, and hair changes more frequently. Mood extremes tend to ease.

*Menopause Type 4: Women in this phase are in later menopause, which begins approximately eight years after menopause. During this phase, symptoms shift to mental, vaginal, urinary, hair, and skin, as well as more muscle and joint pain.

*Menopause Type 5: Defines a woman whose position in the transition is uncertain because she is taking hormones. This reflects women on oral contraceptives or with an IUD that stops menses. This category also includes those who have had a hysterectomy or ablation, but have kept their ovaries (as they will hormonally go through menopause, but experience no bleeding signal).

A woman receives her menopause type after taking Gennev’s free Menopause Assessment. She is then invited to connect with Gennev’s health care team of OB/GYNs certified by the North American Menopause Society, and health coaches certified as Registered Dietitian Nutritionists, for a comprehensive menopause plan based on her type and her unique needs. Her health data throughout her menopause journey and beyond is accessible to her and her unified Gennev health team in one place within Gennev’s menopause platform.

Over the past three years, over 50,000 women have benefited from Gennev’s line of supplements, lubricants, and telehealth services for menopause. This includes telehealth services specializing in gynecology, primary care and lifestyle behaviors as well as natural, quality-sourced wellness products and supplements that support mood, energy, stress response, immune health, joint pain, inflammation, sexual wellness and vaginal health.

Take the Menopause Assessment here. Read the blog post here. Explore Gennev’s Menopause Zeitgeist to learn more about social taboos, symptoms, and surprising gaps in menopause support.

About Gennev

Gennev is the first-of-its-kind online clinic for women in menopause. The company’s mission is to empower every woman to take control of her health in the second half of life. Founded by former Microsoft executive Jill Angelo and former Neutrogena executive Jacqui Brandwynne, Gennev provides telemedicine with menopause-certified OB/GYNs, on-demand telehealth coaching with registered dietitians, plus health and wellness products, community, and free education. Thousands of women globally have completed the Gennev Menopause Assessment to understand where they are in the journey and receive recommended health and wellness solutions. For more information, visit https://gennev.com.

Share article on social media or email:

“AirEvac International is absolutely exhilarated to be both affiliated with and recognized by NAAMTA and the prestige behind this accreditation. Every team member at AirEvac International continually strives to work above and beyond the NAAMTA standards for the benefit of its patients.”

SCOTTSDALE, Ariz. (PRWEB)
June 19, 2020

Following a comprehensive audit of administrative documentation, medical practices, and facilities, the NAAMTA Global has awarded Medical Logistics Management, Inc dba AirEvac International with accreditation for their fixed-wing medical transport program. As a result, AirEvac International joins the NAAMTA Global Alliance and is thus privy to the associated benefits.

NAAMTA’s Alliance members are held in high esteem for meeting stringent requirements that define and influence transport operational excellence. AirEvac International demonstrated compliance in each of the numerous standards, offering documentation on processes for safety, aviation, and medical practices. NAAMTA found their compliance to be evident through employee interviews, on-site evaluations, and process reviews, all of which was conducted using ISO 9001:2015 auditing guidelines.

AirEvac International offers the highest quality of medical transportation care by combining the best medical resources and most efficient response times. As a direct service provider of bedside-to-bedside critical care, AirEvac provides repatriation for patients in North America as well as coordination of emergency evacuation throughout the Caribbean, Mexico, Central and South America.

“AirEvac International prides itself in not only providing exceptional patient care but also for setting the industry standard for patient advocacy,” said Kelly LoCascio, General Counsel and CEO. “With that, we are absolutely exhilarated to be both affiliated with and recognized by NAAMTA and the prestige behind this accreditation. Every team member at AirEvac International continually strives to work above and beyond the NAAMTA standards for the benefit of its patients and we look forward to the advancement and growth of our team under the NAAMTA guidance for years to come.”

Nancy Purcell, NAAMTA Global’s Director of Clinical Operations stated, “NAAMTA Global’s Accreditation program is built on providing standards that focus on quality patient care and the safety of the transport for all involved. The NAAMTA Alliance unifies each accredited organization in the vanguard of continuous improvement for medical transports. Our audit evidenced AirEvac International’s determination to provide outstanding service for the international community. We were very impressed with the expertise of each individual and how their contribution in working succinctly as a team results in successful transports.”

By attaining NAAMTA Accreditation, AirEvac International demonstrates the depth of their medical transport experience through their dedication to improving patient care and cultivating an environment of safety. AirEvac International is made up of industry experts. Now their expertise is proven through a nationally-recognized medical transport accreditation.

About NAAMTA Global

NAAMTA Global is an accreditation standard-bearer for the medical transport industry, offering procedures that include guidelines for developing a quality management system focusing on transport safety, patient care, and continuous improvement. Since its inception in 2009, NAAMTA has worked diligently to be globally recognized by attaining ISO 9001:2015 QMS certification and to implement quality practices into their accreditation program. NAAMTA Global successfully identifies key best practices to improve the standard of performance among EMS providers at a national and global level. Through a dynamic approach to auditing and a vast array of web-based reporting and learning tools for members, NAAMTA distinguishes itself as an accreditation source interested in the improvement of medical transport organizations.

Roylen “Griff” Griffin,

Executive Director

NAAMTA Global

P.O. Box 7

Blanding, UT 84511

http://www.naamta.com

Share article on social media or email:

“The For the Health™ webinar is to start an open dialogue on racial and economic disparities in food allergy. It is my hope that words will move to action and we will see real lasting change.” Emily Brown, CEO of Food Equality Initiative

KANSAS CITY, Mo. (PRWEB)
June 18, 2020

Food Equality Initiative (FEI), a nonprofit with the mission to improve health and end hunger in individuals diagnosed with food allergies and celiac disease announced the first of the “For the Health” webinar series, A Conversation on Race & Food Allergy.

This webinar is scheduled for Friday, June 19, 2020, from 11:00, am EST – 12:00 pm EST.

Intentionally planned on Juneteeth, the national holiday commemorating the end of slavery in the U.S. this panel will bring together health experts to discuss actionable ways that we can end systematic health disparities in food allergy.

The webinar was inspired by this Open Letter to the Allergy Community written by Emily Brown, CEO of Food Equality Initiative, after the murder of George Floyd that has focused the nation’s attention on the public health crisis of police brutality, which targets black men and women.

Emily Brown says this, “The For the Health™ webinar is to start an open dialogue on racial and economic disparities in food allergy. It is my hope that words will move to action and we will see real lasting change.”

The goal of this webinar, For The Health™ is to reduce racial disparities in food allergy. Topics will include:

• 
  The impacts of Social Determinants of Health (SDoH) as it relates to food allergy.
• Community resources and education about racial disparities in food allergy.
• Actionable ways that allies and industry can support organizations committed to a more inclusive environment.

Research shows that Black children are 7% more likely to have food allergies compared to white children, are diagnosed less frequently, receive less medical care, and are more likely to experience anaphylaxis.

The panelist include:

• Emily Brown, Founder, and CEO of Food Equality Initiative
• Denise Woodard, Founder, and CEO of Partake Food s
• Thomas Silvera, President of the Elijah-Alavi Foundation
• Dina Silvera, Mental health advocate, and the executive creative director at G.A.M.E.
• Lakiea Wright-Bello, MD MAT MPH a Board-certified Allergist and the US Medical Director ImmunoDiagnostics-Clinical Affairs at Thermo Fisher Scientific
• Javier Evelyn Founder and CEO of Alerje, recognized in Crain’s 40 Under 40, and founding team member at MedTec Color

The panel will be moderated by:

• Karen Palmer of Karen Palmer Coaching, Certified Professional Coach, school operations consultant and an advocate for food allergy families.
• Linsey Davis Two-time Emmy Award winning correspondent for ABC News and successful children’s book author.

This For The Health™ webinar is sponsored by Thermo Fisher Scientific, Alerje, and Spokin.

To register for this webinar please visit, For The Health™

Share article on social media or email:

Board-certified internist Dr. Michael Farzam.

Neglecting one’s ongoing health problems to avoid the risk of being exposed to viral illnesses can have some less than pleasant unexpected outcomes.

LOS ANGELES (PRWEB)
June 18, 2020

A May 31 article on Yahoo Finance reports on a prominent Los Angeles-based hospital’s recent efforts to encourage those in the community to prioritize their health and begin to start scheduling in-person visits when needed now that protocols have been set to make doctor visits safer. The article reports that many hospitals in Southern California never reached full capacity or experienced the surge in COVID-19 patients they expected. What the hospitals found, the article explains, was that the number of online-visits quickly rose from 150 a week to over 10,000 a week. The hospital community also found that the public was hesitant to step into hospitals or clinics, and many of those who have since returned to receive care for their non-coronavirus issues should have been seen much earlier. Dr. Michael Farzam of House Call Doctor Los Angeles says that, while social distancing remains extremely important, neglecting one’s ongoing health problems to avoid the risk of being exposed to viral illnesses can have some less than pleasant unexpected outcomes.

Dr. Michael Farzam says that house call medicine is a good alternative for individuals in need of general medical care but who are also looking to avoid medical buildings and clinics. Especially in the time of COVID, the board-certified physician says that the advantages of choosing house call doctors continue to increase. In addition to patients not needing to risk worsening their condition through the stress of going to a doctor’s office and sitting in a crowded waiting room full of other ill patients, they can rest comfortably at home without the risk of infecting others while medical care is brought directly to their doorsteps, says Dr. Michael Farzam.

While home visits from doctors might seem quaintly old-fashioned, Dr. Michael Farzam says the service has made a comeback due to advances in medical technology. Much like most other types of technology over the last two decades, medical equipment has miniaturized and become easily portable, allowing doctors to once again bring care directly to patients’ homes without sacrificing the best of 21st-century medical care, Dr. Michael Farzam explains.

There may be added benefits. Dr. Farzam says he can spend an average of 45 minutes with each patient, much longer than most clinic-based doctors are typically allowed. He also adds that, while virtual visits have their place, they also have obvious limitations. He recounts a case where a doctor visited an aging ill-patient with flu-like symptoms. Once the doctor arrived, the physicians immediately smelled the real problem — a gas leak that the elderly individual wasn’t able to smell. Sometimes, notes the doctor, there’s no substitute for showing up.

Readers interested in learning more about board-certified physician Dr. Michael Farzam and House Call Doctor Los Angeles can call (310) 849-7991 or visit https://www.housecalldoctorla.com.

Share article on social media or email: